Share
Welcome to Our Skin, a Personal Discovery Podcast. Each week, host Holly Frey showcases a personal story from someone who lives–and thrives!--while managing psoriasis. Being diagnosed with a chronic skin condition can throw anyone off track, but Our Skin guests have a message of hope: a diagnosis can be an opportunity to discover new things about ourselves, our grit, and our power. In addition to these tales of hope, Frey and her guests plunge into the jaw-dropping, bizarre, and occasionally ...
…
continue reading
Manage episode 489464063 series 3323646
Content provided by Levine Media Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Levine Media Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Though there are plenty of therapeutic alternatives for asthma and chronic obstructive pulmonary disease, or COPD, there are no approved biologics for treating acute exacerbations of these conditions. Connect Biopharma believes that’s an opportunity. It's experimental therapy rademikibart has shown promise treating exacerbations and providing sustained improvements. We spoke to Barry Quart, CEO of Connect Biopharma, about the unmet need the company is seeking to address, how rademikibart works, and Connect’s repositioning as a U.S.-centric company.
570 episodes
))
